Signal transduction chimeric antigen receptor. Medical search. Frequent questions

We designed a lentiviral vector expressing a chimeric antigen receptor with specificity for the B-cell antigen CD19, coupled with CD137 (a costimulatory receptor in T cells [4-1BB]) and CD3-zeta (a signal-transduction component of the T-cell antigen receptor) signaling domains. (nih.gov)
In 2010, James Kochenderfer and colleagues achieved a breakthrough with a CAR T cell therapy, reporting tumour regression in a patient with advanced follicular lymphoma, who received two infusions of autologous T cells genetically engineered to express a CAR specifically recognizing the antigen CD19 expressed on B cells. (nature.com)
The human CD19 antigen is a transmembrane protein expressed from pre-B cells until the terminal differentiation to plasma cells [ 42 ]. (biomedcentral.com)
Ruella M, Kenderian SS, Shestova O, Klichinsky M, Melenhorst JJ, Wasik MA, Lacey SF, June CH, and Gill S. A Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells (CART) for B cell neoplasms . (upenn.edu)
The Addition of the BTK inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma. (upenn.edu)
The chimeric antigen receptor (CAR) T-cell therapy aims to address patients who relapse with tumors that have lost CD19 expression. (bioprocessintl.com)
The two binding domains are in a compact structure that enables high expression and are, like the CD19 CARs, connected to signaling motifs that activate T-cell tumor killing. (bioprocessintl.com)
From the leukapheresis material collected from the patient, enriched CD62L+ cells are activated, then genetically modified by lentiviral vector transduction to integrate the CD19/CD20 CAR plasmid into the T cell genome. (bioprocessintl.com)
CAR-T cells, which incorporate an antibody-derived extracellular receptor and T cell derived intracellular signaling domains, have shown convincing outcomes in certain types of leukemia and lymphoma, including commercial licensure of CD19 CAR-Ts for the treatment of relapsed/ refractory large B cell lymphoma and acute lymphoblastic leukemia. (bdbiosciences.com)
The technique has also shown preliminarily promising outcomes in B cell acute lymphoblastic leukemia (B-ALL), B cell non-Hodgkin's lymphoma (B-NHL), chronic lymphocytic leukemia (CLL), Hodgkin's lymphoma and multiple myeloma in clinical trials targeting CD19, CD20, CD22, CD30 and B-cell maturation antigen (BCMA), with many more under investigation. (bdbiosciences.com)

Uncontrolled or excessive cell division has many different causes, including mutations in cell signaling pathways that drive cell proliferation, remove the normal cell cycle controls or promote cell survival. (promegaconnections.com)
Targeting these mutated and malfunctioning pathways with small molecules that block the aberrant signals of these cellular pathways can stop tumor growth and inhibit its spread. (promegaconnections.com)
Together, with the metalloprotease exercise of LF, the increased ranges of cAMP resulting from EF-CaM activity produce a wide range of cytotoxic effects that embrace altered water homeostasis, which significantly disturbs intracellular signaling pathways. (orthodontistlamesa.com)
Because MAPKKs are essential in main signal transduction pathways, this disruption results in a lower in transcription and subsequent protein synthesis. (orthodontistlamesa.com)
Enriched pathways analysis of these positively correlated genes featured Toll-like receptor and SUMOylation pathways. (preprints.org)
These molecules involved with different oncogenic pathways are referred to as tumor linked antigens (TAA) and represent optimum blocking targets in order to avoid the tumor cell proliferation [9]. (baxkyardgardener.com)
Abnormal receptor activation or dysregulation of the EGFR signal transduction pathways can result from a number of different mechanisms that are potentially relevant to the growth and/or development of human carcinomas [11]. (baxkyardgardener.com)
Erythropoietin-producing hepatocellular A2 (EphA2) is a member of the Eph subfamily with tyrosine kinase activity, plays a key role in the regulation of signaling pathways related to the malignant phenotype of various tumor cells, but its specific regulatory mechanism in colorectal cancer needs to be further clarified. (aging-us.com)
Moreover, cIAPs are required for CD137 signaling toward the NF-?B and MAPK pathways and for costimulation of human and mouse T lymphocytes. (unav.edu)
Studies reveal that chronic exposure of T cells to TNF uncouples TCR signal transduction pathways by impairing the assembly and stability of the TCR/CD3 complex at the cell surface. (biomedcentral.com)
Despite this membrane-proximal effect, TNF selectively uncouples downstream signalling pathways, as is shown by the dramatic suppression of calcium signalling responses, while Ras/ERK activation is spared. (biomedcentral.com)

The CAR programs the recipient's T cells to target an antigen that is present on the surface of tumors. (wikipedia.org)
Similar early clinical trials of CAR T cells in solid tumors in the 1990s using first generation CARs targeting a solid tumor antigens such as MUC1 did not show long-term persistence of the transferred T cells or result in significant remissions. (wikipedia.org)
The agreement is based on one of the improvements to ACT discussed in the December 2011 Nature cancer immunotherapy review , in which autologous T cells isolated from patient blood (not from tumors) are engineered with retroviral vectors carrying chimeric antigen receptors (CARs). (biopharmconsortium.com)
However, due to intricacies of solid tumors and their locations in the human body, treatment of solid tumors with CAR-T cells is facing multiple obstacles, such as the hostile tumor microenvironment, on-tumor/off-tumor toxicities, and undesired antigen specificity [ 2 ]. (ijbs.com)
Furthermore, tumor heterogeneity has a significant impact on both the immune microenvironment and the infiltration of various immune cells within tumors, such as cytotoxic T lymphocytes (CTLs) ( 5 ), myeloid antigen-presenting cells ( 6 ) and cancer-associated fibroblasts (CAFs) ( 7 ). (spandidos-publications.com)

This work prompted CD3ζ intracellular domains to be added to chimeric receptors with antibody-like extracellular domains, commonly single-chain fraction variable (scFv) domains, as well as proteins such as CD4, subsequently termed first generation CARs. (wikipedia.org)
In 2002, Michel Sadelain and colleagues optimized CAR design by integrating the intracellular domains of TCR and the key co-stimulatory receptor CD28 within a single molecule to help sustain T cell expansion, function and persistence. (nature.com)

At the end of culture all four candidates demonstrated equivalent transduction efficiencies and released cytokines specifically in response to BCMA-positive multiple myeloma cell lines. (bmj.com)

A first generation CAR containing a CD4 extracellular domain and a CD3ζ intracellular domain was used in the first clinical trial of chimeric antigen receptor T cells by the biotechnology company Cell Genesys in the mid 1990s, allowing adoptively transferred T cells to target HIV infected cells, although it failed to show any clinical improvement. (wikipedia.org)
CAR comprises an extracellular, cancer-specific antibody fused with the intracellular signaling activation domains of CD3 and co-activation ligands, such as CD28 or 4-1BB [ 17 , 18 ], which provide engineered T cells with an MHC‐independent mechanism through which to kill cancer cells directly. (biomedcentral.com)
Cetuximab is a recombinant, human/mouse chimeric monoclonal antibody that binds specifically to the extracellular domain of the human EGFR [13, 14]. (baxkyardgardener.com)

Cancer immunotherapy by chimeric antigen receptor-modified T (CAR-T) cells has shown exhilarative clinical efficacy for hematological malignancies. (ijbs.com)
We have optimized the transduction and expansion of murine CAR T cells for cancer immunotherapy (DOI: 10.1084/jem. (unil.ch)
cancer immunotherapy signal transduction transforming growth factor-β tumor biology Transforming growth factor-β (TGF-β) is a ubiquitously expressed cytokine that mediates. (silverchair.com)
John Maher Immunotherapy of cancer using chimeric antigen receptor (CAR) T-cells is a rapidly expanding field. (silverchair.com)

Human derived T lymphocytes engineered to express chimeric antigen receptors, which are expanded in vitro culture and then infused into patients exerting robust cytotoxicity after tumor antigen recognition and subsequent activation. (biomedcentral.com)

CARMA Therapeutics, a company that develops chimeric antigen receptor technology, not for T-cells (CAR-T cells), rather, for macrophages, hence the name "CARMA," closed on an initial round of funding to advance its technologies. (shu.edu)

The first chimeric receptors containing portions of an antibody and the T cell receptor was described in 1987 by Yoshihisa Kuwana et al. (wikipedia.org)
ScFv is the antigen-binding domain of CAR structure, which is composed of a single heavy and light chain of monoclonal antibody connected by a linker. (biomedcentral.com)
In 1989, Zelig Eshhar and colleagues realized that the inability of T cells to recognize surface tumour antigens could be overcome by replacing domains of the T cell receptor (TCR) with antibody parts with specificity towards proteins on these cells. (nature.com)
They combined the variable region of an antibody with the constant regions of the TCR chains, thus producing chimeric antigen receptors (CARs) that provided T cells with antibody-type specificity. (nature.com)
Chimeric antigen receptors (CARs) operably link T cell activation domains to the antigen recognition properties of an antibody, thereby redirecting T lymphocytes to cells expressing the antigen. (bmj.com)
Description: The RPA-T8 monoclonal antibody reacts with the human CD8a molecule, an approximately 32-34 kDa cell surface receptor expressed either as a heterodimer with the CD8 beta chain (CD8 alpha/beta) or as a homodimer (CD8 alpha/alpha). (thermofisher.com)
This antibody recognises intracellular C-terminus of human and murine CD79b which is part of the B-cell antigen receptor which constitutes a disulphide linked heterodimer, consisting of CD79a (mb1) and CD79b / B29 polypeptides which are non-covalently associated with membrane bound immunoglobulins on B-cells. (absoluteantibody.com)
Western Blot using anti-CD79b antibody B29/123 (Ab01333) Daudi cell lysates (35µg protein in RIPA buffer) were resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of B29/123 (Ab01333-23.0) at 0.0003 µg/ml before detection using an anti-rabbit secondary antibody. (absoluteantibody.com)
Immunofluorescence staining of fixed Daudi cells with anti-CD79b antibody B29/123 (Ab01333) Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix™ coverslips stained with the chimeric rabbit IgG version of B29/123 (Ab01333-23.0) at 10 µg/ml for 1h followed by Alexa Fluor® 488 secondary antibody (2 µg/ml), showing membrane staining. (absoluteantibody.com)

Antitumor effects of agonist anti-CD137 mAbs are critically dependent on the integrity of cIAPs in cancer mouse models, and cIAPs are also required for signaling from CARs encompassing CD137's cytoplasmic tail. (unav.edu)

B cell maturation antigen (BCMA) is an attractive CAR T cell target to treat patients with multiple myeloma. (bmj.com)

γδ T cells, specifically the Vγ9Vδ2 subset, which is the dominate subset among γδ T cells in human peripheral blood, recognize target cells in a human leukocyte antigen (HLA)-independent manner. (nature.com)
Another ACT developed in parallel to CAR T cells is engineering T cells to express TCRs that recognize tumour-associated antigens. (nature.com)
Efficacy was dependent on the number of CD8+ T cells able to recognize tumor antigens that infiltrated the malignant tissue. (unav.edu)
Taking advantage of the diverse γδ TCR repertoire or other ligand-receptor interactions, γδ T cells can recognize a broad spectrum of tumor-associated antigens (TAAs) in a major histocompatibility complex (MHC)-independent manner, thereby activating downstream pleiotropic effects. (explorationpub.com)
1 T cells are engineered to express CARs through viral vectors, enabling them to recognize specific target antigens. (bdbiosciences.com)

We aim to elucidate factors in the solid tumor microenvironment that can inhibit CAR T cells and develop decoys/traps or signaling switch receptors to rescue/enhance their activity. (unil.ch)

In biology, chimeric antigen receptors (CARs)-also known as chimeric immunoreceptors, chimeric T cell receptors or artificial T cell receptors-are receptor proteins that have been engineered to give T cells the new ability to target a specific antigen. (wikipedia.org)
As sign transduction through the EGFR leads to activation of wild-type K-Ras proteins, tumor cells with activating K-Ras somatic mutations are dynamic and is apparently individual of EGFR rules [13] continuously. (baxkyardgardener.com)
Eph receptors and their ligands, Ephrin proteins (Eph receptor interacting proteins), play a key role in many pathological states (abnormally elevated RTK activity is a feature of most human cancers), and therefore Eph receptors can be used as potential drug targets [ 9 , 10 ]. (aging-us.com)
In addition to plexins, various other proteins have been implicated either as receptors for semaphorins or as components of the semaphorin receptor complex ( Pasterkamp and Kolodkin, 2003 ). (rupress.org)
Transfection of mRNAs encoding the chimeric constructs achieved functional expression of the proteins able to act on their targets. (unav.edu)

Evidence for CD4 + T-cell involvement in autoimmune disease pathogenesis and for paracrine calcitriol signaling to CD4 + T lymphocytes is summarized to support the thesis that calcitriol is sunlight's main protective signal transducer in autoimmune disease risk. (frontiersin.org)

CAR recognizes tumor-associated antigen targets and activates intracellular signals that stimulate proliferation of T cells, which identify and kill tumor cells. (biomedcentral.com)

We tested four candidate anti-BCMA CARs each comprised of unique single chain variable fragments from antibodies specific to BCMA fused to CD3zeta and CD137 (4-1BB) signaling domains. (bmj.com)
CD137 (4-1BB) is a member of the TNFR family that mediates potent T cell costimulatory signals upon ligation by CD137L or agonist monoclonal antibodies (mAbs). (unav.edu)
We show that cIAP1 and cIAP2 are physically associated with the CD137 signaling complex. (unav.edu)
To make the most of these approaches, we have constructed chimeric mRNAs encoding single-chain IL-12 fused to single-chain fragment variable (scFv) antibodies that bind to transforming growth factor b (TGF-b) and CD137 (4-1BB). (unav.edu)

One major research focus is the characterization of leukemia-associated intracellular signal transduction networks and preclinical testing of kinase inhibitors in genetic subtypes of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). (chop.edu)
In addition to the tyrosine kinase inhibitors (TKIs) for Philadelphia chromosome-positive ALL, immunotherapeutic agents, blinatumomab, inotuzumab ozogamicin (INO), and chimeric antigen receptor (CAR) T cells, are changing the treatment paradigm for ALL. (biomedcentral.com)
This binding inhibits the activation from the tyrosine purchase AZD8055 kinase receptor [15] as well as the connected downstream signaling leading to inhibition of cell development, induction of apoptosis and reduced matrix metalloproteinase and vascular endothelial development factor creation [13]. (baxkyardgardener.com)
Ligation of MHC-I/peptide complexes presented by antigen-presenting cells (APCs), triggers the recruitment of lymphocyte-specific protein tyrosine kinase (Lck), which leads to lymphokine production, motility and cytotoxic T lymphocyte (CTL) activation. (thermofisher.com)
Here, we show that plexin-B family members stably associate with the receptor tyrosine kinase ErbB-2. (rupress.org)

Cluster of differentiation 8 (CD8), a type I transmembrane glycoprotein of the immunoglobulin family of receptors, plays an integral role in signal transduction, and T cell differentiation and activation. (thermofisher.com)

For the large number of hepatocellular cancer patients who currently have such limited, poor clinical options, a novel tumor antigen-directed NK engager is needed. (biospace.com)
They can also be used to disrupt the function of growth factor receptors found on the cell surface that help cancer cells divide. (promegaconnections.com)
Cancer cells use checkpoints to evade detection by T cells by signaling that they are 'normal' cells. (promegaconnections.com)
The binding of specific T cell receptors (TCR) to major histocompatibility complex (MHC)/antigen complexes on cancer cells induces the TCR/CD3-mediated signal transduction pathway and stimulates the release of specific toxins (perforin and granzyme) for cancer elimination [ 6 , 7 ]. (biomedcentral.com)
With this assessment, we attempt zinc bioavailability to describe the particular sophisticated regulation overall performance from the Hippo signaling circle within most cancers advancement, such as it's position in signal transduction, metabolic rules, along with tumor development, as well as growth SR-4370 price remedies targeting the Hippo pathway.Aberrant phrase involving glycosphingolipids is a characteristic of cancer cellular material and is linked to their malignant components. (wee1-receptor.com)

The Eph receptor family is the largest family of receptor tyrosine kinases and is a key regulator of cell growth, differentiation and motility [ 6 - 8 ]. (aging-us.com)
The classical mode means that EphA2 inhibits positive signaling of ligands and tyrosine kinases, thereby suppressing tumorigenesis. (aging-us.com)

FasT CAR platform are able to concurrently activate and transduce resting T cells into a single "concurrent activation-transduction" step using XLenti vectors derived from lentivirus. (biomedcentral.com)
T cells are modified ex vivo by transduction with viral vectors containing CAR or other modifications of interest. (bdbiosciences.com)

co-administration of StxB-antigen recombinant protein with α-galactosylceramide (α-GalCer) increases the effectivity of antigen delivery during StxB-mediated internalization. (orthodontistlamesa.com)

The T cells expressing CARs recognized and eliminated target cells, and produced interleukin 2 in the presence of the antigen, providing a proof of concept that this approach triggers a cellular immune response. (nature.com)

However, relapse of primary disease remains a major obstacle after CAR T cells therapy, and the majority of relapses present a tumor phenotype with retention of target antigen (antigen-positive relapse), which highly correlate with poor CAR T cells persistence. (biomedcentral.com)

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell. (upenn.edu)

Our data indicate that ErbB-2 is an important component of the plexin-B receptor system and that ErbB-2-mediated phosphorylation of plexin-B1 is critically involved in Sema4D-induced RhoA activation, which underlies cellular phenomena downstream of plexin-B1, including axonal growth cone collapse. (rupress.org)

One of these of this may be the Epidermal Development Aspect Receptor (EGFR) family members. (baxkyardgardener.com)
The EGFR family is a combined band of cell surface area receptors implicated in the growth of normal epidermal tissue. (baxkyardgardener.com)
The resulting signaling output from activated EGFR is usually highly dependent on the activating ligand, as well as the cellular levels of other co-receptors like EGFR members [12]. (baxkyardgardener.com)
Furthermore, EGFR acts as a point of integration for signals arising from G-proteinCcoupled receptors and cytokine receptors, thus it can cross-talk with various heterologous receptors activated by neurotransmitters, lymphokines and stress inducers [12]. (baxkyardgardener.com)

Other similar second-generation CARs subsequently emerged, incorporating different co-stimulatory domains, such as 4-1BB, which Crystal Mackall and colleagues showed can decrease the T cell exhaustion induced by continuous CAR signalling, thereby improving antitumour efficacy. (nature.com)

Many of us defined how their overexpression can impact intra cellular signaling walkways, increasing the cancerous phenotypes regarding most cancers tissue, which includes his or her metastatic possible along with invasiveness. (wee1-receptor.com)

Engineered chimeric antigen receptor (CAR) T cell therapies (CAR-T) are now commercially available to treat certain leukemias and lymphomas. (bdbiosciences.com)

A second major focus is preclinical testing of chimeric antigen receptor (CAR) T cell immunotherapies in childhood AML and ALL. (chop.edu)
Chimeric antigen receptor T cell (CAR-T cell) therapy is a relatively new, effective, and rapidly evolving therapeutic for adoptive immunotherapies. (biomedcentral.com)

In 1991, chimeric receptors containing the intracellular signaling domain of CD3ζ were shown to activate T cell signaling by Arthur Weiss at the University of California, San Francisco. (wikipedia.org)

Physiologic recognition of tumour antigens by T cells is mediated by the TCR-CD3 complex. (nature.com)

Furthermore, Cetuximab promotes the receptor dimerization, degradation and internalization resulting in receptor down-regulation [16]. (baxkyardgardener.com)

iNK cells expressed a favorable combination of multiple activation and few inhibitory receptors that corresponded to more potent cytolytic activity against HCC targets. (biospace.com)

The molecular mechanisms of plexin-mediated signal transduction are still rather unclear. (rupress.org)
Additionally, induced co -expression of luciferase, EGFP, and the melanosomal antigen gp100 facilitates studies on the underlying immunological mechanisms. (unav.edu)
On the basis of these data, it is proposed that T-cell survival and effector responses are driven by antigen-independent, cytokine-dependent mechanisms, and that therapeutic strategies that seek to restore T-cell homeostasis rather than further depress T-cell function should be explored in the future. (biomedcentral.com)

M112.357673) and of small molecule responsive T cell-signaling mediators for improved tumor control and safety. (unil.ch)
The bi-stable switch would enable T cells to integrate signals from pathogens, hormones, cell-cell interactions, and soluble mediators and respond in a biologically appropriate manner. (frontiersin.org)

Disease relapse following CAR T cell therapy can be categorized into two major patterns: target antigen loss relapse or antigen-positive relapse. (biomedcentral.com)
Chimeric Antigen Receptor (CAR) T-cell therapy has recently been approved in the USA and Europe for the treatment of relapsed B-cell malignancies, with potential further application in a broad range of tumour types. (ukri.org)
Chimeric Antigen Receptor (CAR) T-cell therapy is growing in application. (ukri.org)
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf. (upenn.edu)

In humans, the MHC is called the human leukocyte antigen (HLA) system and is located on the short arm of chromosome 6, near the complement genes. (medscape.com)
There are 14 Eph receptors in the human genome, which can be subdivided into EphA and EphB subclasses. (aging-us.com)
The structure of the mu/pseudo light chain complex on human pre-B cells is consistent with a function in signal transduction. (absoluteantibody.com)
Animal modeling and human mechanistic data are summarized to support the view that vitamin D probably influences thymic negative selection, effector Th1 and Th17 pathogenesis and responsiveness to extrinsic cell death signals, FoxP3 + CD4 + T-regulatory cell and CD4 + T-regulatory cell type 1 (Tr1) cell functions, and a Th1-Tr1 switch. (frontiersin.org)

In ACT, a physician/researcher extracts a patient's antigen-specific immune cells, which are usually found in tumor tissue. (biopharmconsortium.com)

However, the unusual phenotype of synovial T cells, including their profound proliferative hyporesponsiveness to TCR ligation, has challenged the notion that T-cell effector responses are driven by cognate cartilage antigens in inflamed synovial joints. (biomedcentral.com)

CARs are fusion molecules that couple the binding of a tumour-associated cell surface target to the delivery of a tailored T-cell activating signal. (silverchair.com)

For safety, CAR T cells are engineered to be specific to an antigen that is expressed on a tumor but is not expressed on healthy cells. (wikipedia.org)

Calcium mineral signaling is necessary to support erythroid difference and expansion. (immune-source.com)

A low dose (approximately 1.5×10(5) cells per kilogram of body weight) of autologous chimeric antigen receptor-modified T cells reinfused into a patient with refractory chronic lymphocytic leukemia (CLL) expanded to a level that was more than 1000 times as high as the initial engraftment level in vivo, with delayed development of the tumor lysis syndrome and with complete remission. (nih.gov)

γδ T cells express unique T cell receptor (TCR) γ and TCR δ chains, with structural and functional heterogeneity. (explorationpub.com)

By co-expressing a TCR-specific single-chain variable fragment with a Golgi retention signal (TCR-KDEL) along with the CAR, TCR-negative CAR T-cells can be generated with a single viral transduction. (ukri.org)

Anatomy17

Organisms8

Diseases3

Chemicals and Drugs97

Analytical, Diagnostic and Therapeutic Techniques and Equipment25

Phenomena and Processes32

Technology, Industry, Agriculture1

Information Science3

CD1910

Pathways11

Tumors5

Intracellular domains2

Cytokines1

Extracellular3

Immunotherapy4

Derived T lymphocytes1

Macrophages1

Antibody9

Antitumor effects1

Maturation antigen1

Recognize5

Microenvironment1

Proteins5

Lymphocytes1

Tumor-associated1

CD1374

Kinase5

Transmembrane1

Cancer5

Tyrosine2

Vectors2

Recombinant1

Immune response1

Relapses1

Induction1

Downstream1

EGFR4

Cell exhaustion1

Cancers1

Therapies1

Immunotherapies2

Activate T cell1

Recognition1

Internalization1

Targets1

Mechanisms3

Mediators2

Therapy4

Human4

Tissue1

Phenotype1

CARs1

Cells are engineered1

Calcium1

Leukemia1

Chains1

Retention1